This drug delayed rheumatoid arthritis for years after treatment ended
A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with ben
A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with benefits lasting long after treatment ended.
This report comes from Science Daily. The story centres on This drug delayed rheumatoid arthritis for years after treatment ended. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from Science Daily and related outlets covering this beat.
